CoreWeave CEO Michael Intrator insists the $9 billion offer is fair, while ISS urges rejection of the deal, citing Core Scientific's ability to grow independently.
CoreWeave CEO Michael Intrator confirmed the company will not raise its $9 billion all-stock offer for Core Scientific (CORZ), calling it a ‘nice to have, not a need to have.’ Proxy advisory firm ISS has recommended shareholders reject the deal, arguing Core Scientific can continue to grow independently. CoreWeave’s stock has dropped 4.3% following the announcement, while Core Scientific’s stock rose 1.6%, indicating market preference for the company’s independence.